Testing combination malaria drugs for vivax malaria cure
Part of Infections clinical trials.
This study tests new combinations of antimalarial drugs to better cure P. vivax malaria, a type of malaria parasite. You would receive experimental drug combinations and be monitored for about 6 months to see if they work and are safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old and not pregnant or breastfeeding
- You must have P. vivax malaria (confirmed by blood test) with a specific parasite count
- You must have normal G6PD enzyme levels (a blood protein that affects how your body processes certain malaria drugs)
- You cannot have taken antimalarial drugs in the past 2–4 weeks
- You must have normal heart, liver, and kidney function as shown by blood tests and EKG
- You must agree to contact the study team if you develop a fever during the 6-month study period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives healthy volunteers a controlled infection with a type of malaria (vivax) to see how the infection behaves and how well curative anti-malaria medicine works. It may help researchers better design and test future malaria vaccines and treatments.
This study will expose healthy adults to a small number of mosquito bites carrying the P. vivax malaria parasite to learn how many bites are needed to cause infection. Participants will be closely monitored and treated in the hospital to ensure safety.
This trial tests a combination of three malaria medicines in healthy volunteers to see how safe they are and how the body processes them. If you are a healthy non-smoker, you may be able to help researchers understand these drugs better.
This study tests how well a malaria treatment plan works for people with P. vivax malaria who don’t have another malaria type at the same time. It aims to see whether adding or using different medicines (ACT vs chloroquine with tafenoquine) helps clear infection and prevent return of disease.
This trial tests a two-drug combination to safely and quickly clear all stages of P. vivax malaria from your body. You must have confirmed vivax malaria, be within a certain weight range, and agree to hospital stay and follow-up visits over 6 months.
This trial tests a revised dose of a medicine called tafenoquine to more effectively cure vivax malaria (a type of malaria that can come back). It is for people with normal G6PD enzyme levels and a current fever from vivax malaria.
Hear when a new Uncomplicated P. Vivax Mono-infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.